The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy. - Oligonucleotide Therapeutics Society

The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy.

OTS

Ago/siRNA/saRNA

August 5, 2020

SHARE

Post Views: 412

Biscans A, Caiazzi J, Davis S, McHugh N, Sousa J, Khvorova A.

Nucleic Acids Res. 2020 Jul 16

Related articles

Subscribe to our Newsletter

Oligonucleotide Therapeutics Society

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Terms & Conditions

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors

By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login

This website uses cookies and third party services. Ok